Jun 8, 2018 by Brian FeroldiWhy Savara Inc. Is Soaring TodayTraders cheer after the company receives positive analyst coverage. Here's what investors need to know.
Jun 7, 2018 by Brian FeroldiHere's Why Mirati Therapeutics, Inc. Is Rising TodayWall Street cheers after the company announced favorable terms from a just-announced capital raise. Here's what investors need to know.
Jun 7, 2018 by Brian Feroldi, Keith Speights, and Neha Chamaria3 Stocks That Could Put Apple's Returns to ShameHere's why we think these three businesses are poised to outperform.
Jun 7, 2018 by Brian Feroldi, Keith Speights, and Maxx Chatsko3 Dividend Stocks That Pay You More Than IBM DoesOn the hunt for income? Here’s why you should check out these three high-yield stocks.
Jun 6, 2018 by Brian FeroldiNew Store Openings Drive Duluth Holdings' Sales HigherThe company's aggressive store rollout strategy continues to translate into strong top-line growth.
Jun 5, 2018 by Brian FeroldiHere's Why TherapeuticsMD Inc Jumped TodayShares rise after the company receives some bullish analyst praise. Here's what investors need to know.
Jun 4, 2018 by Brian FeroldiThe Probable Reason Behind NovoCure's Double-Digit Drop TodayShares retreat after the company releases details about an upcoming phase 3 trial. Should investors be worried, or is this just market noise?
Jun 1, 2018 by Brian Feroldi, Sean Williams, and Keith Speights3 Top Healthcare Stocks to Buy Right NowHere's why these healthcare specialists believe it's a great time to buy a few shares of these three healthcare winners.
Jun 1, 2018 by Brian Feroldi, Dan Caplinger, and Matt Frankel, CFP3 Top Dividend Stocks With Yields Over 3%Looking to collect a big dividend check? These three stocks have you covered.
May 31, 2018 by Brian FeroldiWhy Curis, Inc. Is Soaring TodayTraders cheer after the company reports upbeat regulatory news. Here's what investors need to know.
May 31, 2018 by Brian FeroldiHere's Why Madrigal Pharmaceuticals Is Skyrocketing TodayShares more than double after the company announces exciting clinical results. Here's what investors need to know.
May 30, 2018 by Brian FeroldiThis News Explains Exact Sciences' Double-Digit Pop TodayShares jump after the American Cancer Society tweaks its recommended guidelines for cancer screening. Here's what investors need to know.
May 29, 2018 by Brian FeroldiHere's Why Infinera Stock Is Falling TodayShares drop after an analyst turns negative on the company's prospects. Here's what investors need to know.
May 29, 2018 by Brian FeroldiThis News Explains TransEnterix's Surging Share PriceThe good times continue for the robotic surgery upstart.
May 25, 2018 by Brian FeroldiHere's Why You Should Crave GrubHub's StockThis market darling is profitable, growing fast, and has plenty of room left to run.
May 23, 2018 by Brian Feroldi, Dan Caplinger, and Matt Frankel, CFP3 Growth Stocks That Could Put Facebook's Returns to ShameOn the hunt for stocks with explosive upside potential? Here's why these three businesses could be for you.
May 21, 2018 by Brian FeroldiWhy Nabriva Therapeutics Stock Is Falling TodayShares dropped after the biotech reported what seemed like good news. What's going on?
May 19, 2018 by Brian Feroldi, Sean Williams, and Keith Speights3 Top Biotech Stocks to Buy Right NowWant to invest in this promising industry but don't know where to start? Here are three stocks that can get the ball rolling.
May 18, 2018 by Brian FeroldiWhy Quotient Ltd. Is Soaring TodayTraders cheer after the company shares some good news with investors. Here's what shareholders need to know.
May 17, 2018 by Brian FeroldiWhy Spectrum Pharmaceuticals, Inc. Is Up Big TodayShares jumped after the company shared new details from an important phase 3 study. Here's what investors need to know.
